| Authors: |
Emborg ME; Preclinical Parkinson's Research Program, Wisconsin National Primate Research Center, University of Wisconsin-Madison, USA; Department of Medical Physics, University of Wisconsin-Madison, USA; Cellular and Molecular Pathology Graduate Program, University of Wisconsin-Madison, USA. Electronic address: emborg@primate.wisc.edu., Metzger JM; Preclinical Parkinson's Research Program, Wisconsin National Primate Research Center, University of Wisconsin-Madison, USA., D'Amour K; Stemson Therapeutics, San Diego, CA, USA., Colwell JC; Preclinical Parkinson's Research Program, Wisconsin National Primate Research Center, University of Wisconsin-Madison, USA; Cellular and Molecular Pathology Graduate Program, University of Wisconsin-Madison, USA., Neumann LC; Preclinical Parkinson's Research Program, Wisconsin National Primate Research Center, University of Wisconsin-Madison, USA., Zhang A; Genentech, South San Francisco, CA, USA., Federoff HJ; Kenai Therapeutics, San Diego, CA, USA; Georgetown University Medical Center, Washington, DC, USA. |
